PL
RMD icon

Parkwood LLC’s ResMed RMD Stock Holding History

Parkwood LLC’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,756
Closed -$215K – 359
2017
Q2 		$215K Sell
2,756
-921
-25% -$65.9K 0.03% 348
2017
Q1 		$265K Sell
3,677
-394
-10% -$27.2K 0.04% 348
2016
Q4 		$253K Buy
+4,071
New +$249K 0.04% 399
2015
Q2 		– Sell
-5,056
Closed -$363K – 545
2015
Q1 		$363K Buy
+5,056
New +$328K 0.05% 310

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkwood LLC's RMD Position: Q3 2017 in Review

Parkwood LLC sold out of ResMed (RMD) in Q3 2017, closing a stake of 2,756 shares — an estimated $215K sold.

Parkwood LLC first reported a position in RMD in Q1 2015 and held it in 4 quarters. The position peaked at $363K in Q1 2015. 363 funds tracked by Wall St. Rank hold RMD as of Q3 2017.

  • Parkwood LLC reported no remaining ResMed position as of Q3 2017 after selling out during the quarter.
  • Parkwood LLC sold 2,756 ResMed shares in Q3 2017, an estimated $215K.
  • Parkwood LLC first reported a position in ResMed in Q1 2015 and held it in 4 quarters.
  • Parkwood LLC's ResMed position peaked at $363K in Q1 2015.
  • 363 funds tracked by Wall St. Rank held ResMed as of Q3 2017.

Based on Parkwood LLC's 13F filing for Q3 2017, filed 1 Nov 2017.